Capital Fund Management S.A. Cure Vac N.V. Transaction History

Capital Fund Management S.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$13.18 - $19.41 $3.08 Million - $4.53 Million	-233,371 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$14.73 - $35.25 $1.96 Million - $4.68 Million	132,757 Added 131.95%	233,371 $4.58 Million
Q4 2021 Feb 10, 2022	BUY	$33.72 - $48.22 $3.39 Million - $4.85 Million	100,614 New	100,614 $3.45 Million

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $514M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.